We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Neuroinflammation

Product News   Jan 19, 2017 | BioLegend

 
Neuroinflammation
 
 
Advertisement
 

Related Product News

Movers and Shakers in Biobusiness Report

Product News

The seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.

READ MORE

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

Product News

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.

READ MORE

Impel Neuropharma Presents Data for the 2020 Migraine Trust Virtual Symposium

Product News

Impel NeuroPharma announced that it has presented patient-reported outcomes data from the Company’s pivotal Phase 3, open-label study “STOP 301” of INP104 (dihydroergotamine mesylate) or DHE using the company’s proprietary POD technology, for the treatment of acute migraine in an oral presentation at the Migraine Trust Virtual Symposium (MTIS) to be held from October 3-9, 2020.

READ MORE

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE